Pharmacological treatment of osteoporosis for people over 70. (Q36868372)

16 August 2017

1 reference

title

Pharmacological treatment of osteoporosis for people over 70. (English)

1 reference

16 August 2017

0 references

M Jesús Moro Alvarez

1

1 reference

16 August 2017

Manuel Díaz-Curiel

series ordinal

2

1 reference

16 August 2017

publication date

1 June 2007

1 reference

Aging Clinical and Experimental Research

16 August 2017

published in

1 reference

16 August 2017

volume

19

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

246-254

1 reference

Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Vitamin D3 and calcium to prevent hip fractures in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Improving compliance and persistence with bisphosphonate therapy for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Systematic assessment of the quality of osteoporosis guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Risedronate reduces the risk of first vertebral fracture in osteoporotic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Teriparatide for severe osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Efficacy and safety of oral weekly ibandronate in the treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two-year, double-masked, dose-ranging, placebo-controlled PREVOS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324697

21 January 2018

Identifiers

DOI

10.1007/BF03324697

1 reference

16 August 2017

1 reference